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wide association study (GWAS) looking for associations between all possible 21-mers; this 23 approach generally failed to identify mechanisms that explained the resistance phenotype. In 24 order to decrease the genomic noise associated with population stratification, we compared four 25 phylogenetically-related pairs of isolates with differing susceptibility profiles. RNA-Sequencing 26 (RNA-Seq) was performed on paired isolates and differentially expressed genes were identified. 27
In these isolate pairs, we identified four different potential mechanisms, highlighting the difficulty 28 of broad AMR surveillance in this species. To verify and validate differential expression, 29 amplicon sequencing was performed. These results suggest that a diagnostic platform based on 30 gene expression rather than genomics alone may be beneficial in certain surveillance efforts. 31
The implementation of such advanced diagnostics coupled with increased AMR surveillance will 32 potentially improve A. baumannii infection treatment and patient outcomes. 33 34 isolates with variable AMR phenotypes. The results provide additional detail to understand AMR 103 mechanisms in A. baumannii and identify targets for advanced diagnostics that will provide 104 appropriate therapies for more effective patient treatment. 105 106 Methods: 107 108 Isolate description and growth: A total of 107, largely geographically confined isolates, were 109 identified for sequencing based on collection from different body sites and clinical matrices. All 110 isolates were classified as A. baumannii based on orthogonal, clinical laboratory techniques. A 111 description of all sequenced isolates is shown in Table S1 . Samples were streaked from 112 glycerol stocks onto Mueller Hinton (MH) (Hardy Diagnostics, Santa Maria, CA) agar plates and 113 incubated at 37°C for 24 h. Inoculated plates were checked for appropriate colony growth and 114 morphology the following day prior to DNA extraction. 115 116 Genomic DNA extraction and Sequencing. Genomic DNA was extracted from a single 117 isolated colony for each sample using the DNeasy Blood and Tissue Kit (Qiagen, Valencia, CA, 118 USA) following the recommended protocol for Gram-negative bacteria. Sample DNA was 119 fragmented using the QSonica q800 ultrasonic liquid processor (QSonica, Newtown, CT, USA). 120 Sonication parameters were optimized to produce fragment sizes of 600 to 700 base pairs 121 (time: 3 minutes, pulse: 15s (Pulse On), 15s (Pulse Off), amplitude: 20%). Libraries were size 122 selected using Agencourt AMPure XP beads (Beckman Coulter, Brea, CA) in order to remove 123 small and large fragments outside of the required size range. Genome libraries were prepared 124 using the KAPA Hyper Library Preparation Kit with Standard PCR Library Amplification (Kapa 125 Biosystems, Wilmington, MA) and sequenced on an Illumina MiSeq using V3 sequencing 126 chemistry (Illumina Inc., San Diego, CA). 127
For MinIon sequencing, DNA was extracted with the GenElute Bacterial Genomic DNA kit 128 (Sigma-Aldrich Inc., St. Louis, MO), taking care to limit DNA shearing. Long read sequencing 129 was performed using Oxford Nanopore technologies on a MK1B MinION device using a R9.4 130 Sequence assembly and MLST typing. Illumina-derived whole genome sequence data was 136 assembled with SPAdes v3. 10 (48) . Contigs that aligned against known contaminants or 137 contained an anomalously low depth of coverage compared to the average depth of coverage 138 on a per genome basis were manually removed. The MLST profiles were extracted from whole 139 genome sequence (WGS) assemblies using BLAST-based methods (49) using both the Oxford 140 (50) and Pasteur systems (51) . Annotation on all genomes was performed with Prokka v1.13 141 (52). Hybrid assemblies were generated with combined Illumina and MinION data with was identified with a point biserial correlation method. In addition to differences in coding region 202 sequences (CDSs), individual SNPs and indels were identified through the analysis of Kmers. In 203 this approach, the reverse complement was taken for all genomes so that both strands were 204 included in the analysis. All 21-mers were then identified with Ray-surveyor (78) and placed into 205 a presence absence matrix; the choice of 21-mers was to ensure a short enough length to 206 hopefully identify single mutations. The frequency of Kmers in each phenotype was then 207 calculated with a custom Python script 208 (https://gist.github.com/jasonsahl/e9516b2d940ad2474ba6e97f5b856440). 209 210 Machine learning approach for AMR mechanism identification. Associations of Kmers of 211 length 21 with each AMR mechanism were identified with Kover v2.0.0 (79) using default 212 parameters. Annotation for Kmers was performed by mapping Kmers against annotated coding 213 regions with BLASTN. 214 215 in silico screen of antimicrobial resistance elements. To find previously characterized 216 antimicrobial resistance mechanisms, we screened paired genomes with LS-BSR in conjunction 217 with Diamond (80) and the Comprehensive Antimicrobial Resistance Database (CARD) (31). 218
We also selected resistance genes from the literature associated with antimicrobials screened in 219 this study (Table S3) 30min with shaking at 37°C. Two volumes of RNAprotect Bacteria Reagent (Qiagen, Valencia, 232 CA, USA) were added to all samples and incubated at room temperature for 5min, followed by 233 centrifugation for 10min at room temperature, at a speed of 5000 x g. The supernatant was 234 decanted and the treated cell pellets were stored at -80°C. Total RNA was extracted using the 235 RNeasy Mini Kit (Qiagen, Valencia, CA, USA) following recommended protocol #4 beginning at 236 step 7 and continuing to protocol #7. A DNase I treatment was included for step 2 in protocol #7. 237
Extracted RNA was immediately stored at -80°C. 238 239 mRNA isolation. RNA quality and quantity were checked by Agilent 2100 Bioanalyzer with the 240 RNA 6000 Nano Kit (Agilent Technologies, Santa Clara, CA, USA). mRNA was isolated from 241 total RNA using the MICROBExpress kit (Thermo Fisher Scientific, Waltham, MA) following the 242 manufacturer's protocol. Isolated mRNA was quantified and checked for rRNA depletion on the 243 bioanalyzer with an additional RNA Nano chip prior to sequencing. for differentially expressed regions identified in the RNA-Seq analysis (Table S4) ; a 264 constitutively expressed target (locus tag: IX87_18340), based on analysis of RNA-Seq data, 265 was included for normalization. cDNA was amplified with the following protocol: 1X Promega 266 PCR Master Mix (Promega, Fitchburg, WI), 2.5µL cDNA template, and multiplexed primer 267 concentrations are listed in Table S4 . Gene specific PCR parameters were as follows: initial 268 denaturation at 95°C for 2m, 30 cycles of denaturation at 95°C for 30s, annealing at 55 o C for 269 30s, and extension at 72°C for 45s, with a final extension at 72°C for 5m. Included on each 270 primer was a universal tail (85) Table S1 . 290 291
Results: 292 293
Identification of isolates analyzed in the current study. In this study, we sequenced 107 294 isolates identified by laboratory methods to be A. baumannii. These isolates were 295 retrospectively identified from our collection and sequenced to reflect a range of years and 296 isolation sources (Table S1 ). Of the 107 genomes sequenced in this study, only 84 were 297 confirmed A. baumannii (Table S1 ) isolates based on a global WGS phylogenetic analysis 298 ( Figure 1 ). In order to define and add context to the phylogenetic diversity of genomes 299 sequenced in this study, more than 3,000 publicly available A. baumannii genomes were 300 included in the analysis ( Figure S1 ). 301 302 Antimicrobial resistance profiles of isolates analyzed. AMR profiles were identified for 95 of 303 the isolates across 12 drugs, including all A. baumannii (Figure 1 , Table S2 ). Twelve isolates 304 were excluded due to either difficult to interpret MIC results or inconsistent results across 305 replicates. Some test strips were discontinued during the course of this experiment and were 306 therefore marked as missing in the antibiogram. 307
Antibiograms were obtained for the majority of isolates across all tested drugs (Table S2) From the A. baumannii phylogeny, isolates were identified that were closely related based 319 on phylogenetic distance, but differed in their antibiograms. These isolate pairs ( Figure 2 , Table  320 2) were the subject of additional investigation in order to identify cryptic resistance mechanisms 321 based on a common genomic background. 322 323 in silico AMR profiling of all sequenced Acinetobacter isolates. All proteins from the CARD 324 database (n=2,420) were aligned against 107 sequenced genomes with LS-BSR in conjunction 325 with Diamond. Proteins that were highly conserved in at least 5 genomes were mapped against 326 the phylogeny and demonstrate variable conservation of AMR-associated proteins (Figure 3 , 327 Table S5 ). Some proteins had a clear phylogenetic distribution, where they were either 328 conserved across almost all Acinetobacter (e.g. OXA-64 (OXA-51 family)), conserved across 329 phylogenetic groups in A. baumannii (e.g. aminoglycoside resistance genes (APH-6): 330 AAC23556.1), or were variably conserved (e.g. aminoglycoside adenyltransferase (ANT(2")-Ia): 331 AAC64365.1), suggesting horizontal gene transfer. 332 333 in silico screening of paired isolate genomes. The 84 confirmed A. baumannii genomes 334 were screened for the presence of AMR-associated genes from the CARD database with LS-335 BSR. For 2 isolate pairs, no obvious differences were observed in resistance genes between 336 variably resistant pairs ( Figure S2 , Table S5 ). For TG22182 (R) and TG22627 (I), one CARD 337 gene was differentially conserved (CAE51638) and is associated with an aminoglycoside 338 phosphotransferase, although no differences were observed in resistance to the tested 339 aminoglycoside, gentamicin. Multiple differences were observed between the distribution of 340 CARD genes between TG22653 (R) and TG60155 (I) ( Figure S2 ), although the antibiograms 341 only differed in the resistance to two antimicrobials and the genomes differed by only 27 core 342 genome SNPs. 343 344 Screen of previously described AMR mechanisms. A list of mechanisms associated with 345 AMR in A. baumannii (Table S3 ) were screened against genomes sequenced in this study with 346 LS-BSR ( Figure S3 ). Genomes were also screened for mechanisms associated with resistance 347 to the following specific drugs: 348 349 Quinolones. The gyrA S82L mutation has previously been shown to confer resistance to 350 quinolones in Acinetobacter (29). Of the resistant A. baumannii strains (n=73), 72 (~99%) 351 contained the leucine (L) residue at position 82; the one exception was TG22162, which had the 352 serine (S) residue. All susceptible strains had the serine residue at this position, suggesting that 353 this mutation is the primary mechanism conferring quinolone resistance in analyzed strains. 354
355
Trimethoprim. All tested A. baumannii isolates were resistant to trimethoprim. An in silico screen 356 of folA ( Figure S3 ), which has been associated with target site alteration and trimethoprim 357 resistance (25), demonstrated that all genomes contained this gene, although there was some 358 variation in the peptide identities. As susceptible strains were not identified through screening, 359
we cannot test the genotype/phenotype relationship for this compound, although based on 360 published results, folA appears to be the associated mechanism. 361 362 Beta-lactams: The ampC gene in A. baumannii is a class C beta-lactamase (87). A screen of 363 the ampC peptide sequence against A. baumannii isolates sequenced in this study indicates 364 that almost all genomes have a highly conserved ampC gene at the nucleotide level, but have 365 widely different antibiograms (Table S2, Figure S3 ). This demonstrates that the 366 presence/absence of this gene alone has little predictive value on beta-lactam resistance in A. 367
baumannii. 368
The insertion element ISAba1, in conjunction with bla OXA-51-like genes, has been shown to 369 confer resistance to carbapenems (22) . Genomes in this study showed a correlation (>0.8 370 correlation coefficient) between ISAba1 conservation and resistance to 2 beta-lactams (XM,TX). 371
Many of the ISAba1 transposases were split across multiple contigs in Illumina assemblies, 372 likely due to a repeat region that could not be resolved during assembly. Furthermore, copies of 373 this region were likely collapsed during the short read assembly. For example, for the 8 isolates 374 for which draft genomes and complete genomes were generated in this study, only a single 375 copy of ISAba1 was observed in the draft genome, while 9-26 copies were observed in 376 complete genomes. Additionally, all of the paired isolates in this study contained ISAba1 and a 377 bla OXA-51-like gene but showed variable antibiograms to at least one beta-lactam, suggesting that 378 the conservation of this region alone did not explain the resistance phenotype. 379 Some genes associated with efflux (adeA, adeB) were missing from several genomes 380 ( Figure S3 ) that showed susceptibility to a number of drug families. Some genomes contained 381 these regions but were also susceptible to beta-lactams, suggesting multiple genotypes result in 382 the same resistance or susceptibility phenotype. 383
384
Macrolides. Although ermB has been associated with macrolide resistance in A. baumannii, the 385 gene was not detected in any genome sequenced in this study, based on a LS-BSR analysis 386
( Figure S3 ). The mefA gene was also screened, as it has been demonstrated to provide 387 macrolide resistance, but the gene was highly conserved, even in azithromycin susceptible 388 strains ( Figure S3 ). Resistance to macrolides has also been associated with efflux, although 389 differences in efflux cannot be investigated with genomics alone. 390
391
Aminoglycosides. Four genes associated with aminoglycoside resistance were screened 392 against genomes with LS-BSR. None of the 4 regions (aacC1, aphA6, aadA1, aadB) previously 393 associated with aminoglycoside resistance showed any association (correlation coefficient <0.5 394 0) with resistance to gentamicin in genomes screened in this study ( Figure S3 ). 395 396 Machine learning approaches. For most of the tested drugs, the machine learning method 397 Kover identified regions that were associated with resistance across the A. baumannii isolates 398 tested in this study (Table 3) , based on all possible 21-mers. In almost all cases, the frequency 399 of these Kmers could not completely distinguish between resistant and susceptible phenotypes, 400 suggesting that the large number of associated Kmers identified by Kover are likely not 401 biologically meaningful. 402
403
Genome wide association study (GWAS). To identify genotype/phenotype associations, we 404 performed a GWAS analysis by splitting up isolates into resistant/susceptible groups for each 405 drug; for this analysis we ignored isolates with an intermediate phenotype in order to isolate the 406 mechanism. Using CDS conservation, we failed to identify a clear genotype/phenotype 407 relationship across all Acinetobacter across all drugs. This suggests that genomic analyses 408 alone can fail to comprehensively identify AMR mechanisms in Acinetobacter. When the 409 analysis was repeated for only A. baumannii genomes using both coding regions and Kmers, 410 significant associations were identified (Table 4 ). For ceftriaxone (TX), all susceptible strains 411 (n=3) were missing ISAba1 (ABLAC_32600), while 66 of 67 resistant strains contained this 412 region; the small number of genomes analyzed limits the power of this analysis. In spite of this 413 correlation, the lack of broadly conserved genomic regions associated with resistance directed a 414 paired genome analysis into the identification of novel or cryptic genotype/phenotype 415 associations. 416 417 RNA-Seq and differential expression (DE) analysis. For isolate pairs where a clear 418 genotype/phenotype relationship was not identified, RNA was extracted and cDNA was 419 sequenced. Despite implementing methods to enrich mRNA, ~20% rRNA+tRNA presence was 420 observed in all samples (Table S8) . For each pair, all coding and intergenic sequences were 421 combined into a single file and de-replicated. Reads were mapped against these regions, 422 normalized, and differential expression was identified using DESeq2. Results were then 423 identified for the following isolate pairs: 424 425 Pair 1. Multiple differentially expressed genes were identified that were upregulated in the 426 resistant strain (TG22182) ( Table 5 ). One of these regions was a PER-1 beta-lactamase gene 427 (bla PER-1 )(EA714_008075) that is not broadly conserved across ST368 genomes ( Figure S3 ) 428 and appears to be present on a transposon. A screen of this gene against other ST368 429 genomes isolated from diverse geographic locations suggested that there was an acquisition of 430 this region in a single sequence type and a clear phylogenetic effect ( Figure S4 ). Indeed, a 431 genomic island was identified in both the resistant and intermediate genomes between two 432 transposases (Figure 4a ) that includes a Glutathione S-transferase gene (EA674_08405) that 433 was also upregulated in the resistant strain (11.2x up-regulation); this region has previously 434 been associated with beta-lactam resistance (88). The operon structure was similar between 435 resistant and intermediate strains, with the exception of an IS91 transposon that was between 436 an IS26 transposon and bla PER-1 . The operon structure for the resistant strain that contained an 437 IS91 transposon was determined to be highly similar with an ISCR1 (Insertion sequence 438 Common Region) element. Within the ISCR1 element is an oriIS (origin of replication) region 439 that allows for rolling-circle replication and transposition of the ISCR1 element. Within the oriIS 440 are two outward-oriented promoters (P OUT ) that have been shown to affect downstream gene 441 expression (89). The resistant strain, TG22182, has both P OUT promoters associated with 442 increased gene expression directly upstream of the bla PER-1 gene (Figure 4a ). The more 443 susceptible strain, TG22627, has neither of the P OUT promoters upstream of its bla PER-1 gene. 444
Additionally, the composition of the bla PER-1 gene between isolates was different, with a different 445 coding length as well as composition in the first 12 amino acids of the peptide. 446
Additionally, a glutathione S-transferase family gene (EA674_008405) and the carbapenem 447 susceptibility porin carO (EA674_000940) gene were highly expressed in TG22182 (R) in 448 comparison to TG22627 (I). Both of these genes have been shown to confer resistance to beta-449 lactams and specifically carbapenems (90). Both isolates in Pair 1 also contain an OXA-51 beta-450 lactamase gene (bla OXA-51 ) (EA674_011070), although the gene is slightly up-regulated (4.5x) in 451 TG22627 (I). TG22627 also showed higher expression of other genes associated with AMR 452 including adeI (EA674_003605)(11x), adeB (EA674_009735)(9.5x), adeA 453 (EA674_009730)(9.6x), and adeJ (EA674_003600)(9.6x); however, the up-regulation of genes 454 in the AdeABC pump have previously been demonstrated to not confer aminoglycoside 455 resistance (23). This suggests that the action of the PER-1 beta-lactamase is more effective 456 than other proteins associated with efflux or other oxacillinases in resistance to ceftriaxone (TX) 457 and ceftazidime (TZ). The PER-1 beta-lactamase protein has also been associated with 458 virulence in A. baumannii (91) and has also been associated with resistance to beta-lactams 459 (92). The detection of the bla OXA-51 and ISAba1 regions in these genomes revealed nothing 460 about their susceptibility to TX or TZ. 461 462 Pair 2. Twenty-four differentially-expressed regions were observed between Pair 2 isolates 463 (TG31302, TG31986) at a Wald stat value of 10 (Table S6 ). None of these regions were 464 associated with known mechanisms of AMR in A. baumannii. The two isolates contained a 465 class-D beta-lactamase gene (bla OXA-51 ) and a class-C beta-lactamase gene (ampC). There was 466 no significant difference in gene expression of these regions between isolate pairs. 467
The composition of each beta-lactamase was determined at the nucleotide and peptide 468 level. A protein alignment of ampC between TG31302 (I) and TG31986 (R) revealed a single 469 amino acid difference (R to G) at position 172 ( Figure S5 ) in the PAZ domain. This non-470 synonymous mutation falls within the second of three characteristic conserved motifs, RxY 150 xN, 471
for all class C serine beta-lactamase sequences (93). Although this mutation has not been 472 previously associated with increased activity or misfolding of the protein, other mutations in 473 ampC gene have (94), suggesting that this mutation may confer increased hydrolyzing activity 474 against beta-lactams, although additional validation work is required to test this hypothesis. 475 A continuous stretch of 17 genes was upregulated in TG31986 (R) (EA743_011445 -476 EA743_011530) (Table S7 ). Nine genes within this region were in the top 30 differentially 477 expressed genes in this analysis, including: recombinase recA (EA743_011455), outer 478 membrane protein assembly factor bamA (EA743_011495), 30S ribosomal protein S12 479 methylthiotransferase rimO (EA743_011530), UMP kinase gene pyrH (EA665_011490), RIP 480 metalloprotease rseP (EA743_011500), a gene coding for an OmpH family outer membrane 481 protein (EA743_011490), a phosphatidate cytidylyltransferase gene (EA665_011475), a 1-482 deoxy-D-xylulose-5phosphate reductoisomerase gene (EA665_011470), and a di-trans,poly-cis-483 decaprenylcistransferase gene (EA665_011480). The outer membrane protein (OMP) H, a 484 homolog of the Skp protein in E. coli (95), has been classified as a chaperone protein involved 485 in the folding of BamA. Previous research has shown a correlation between upregulation of 486 molecular chaperones when exposed to antimicrobials and the bacterium's improved ability to 487 tolerate antimicrobial stress (96). Researchers have demonstrated that the skp gene in E. coli is 488 an important stress-associated gene (97) that may be associated with AMR (98). 489 490 Pair 3. Of 94 genomic regions that were significantly differentially expressed (Walt stat >10 or <-491 10) (Table S8 ) between this isolate pair, one of the significant differences was between an 492 bla OXA-51 family (OXA-65) beta-lactamase gene (EA667_019445), which showed 1.9x up-493 regulation in the resistant strain. Interestingly, 79 bases separated the end of insertion element 494 ISAba1 and the start codon of bla OXA-51 in sample TG29392 (R). Previous research has 495 demonstrated that this bla OXA-51-like gene is conserved across A. baumannii lineages, but only 496 genomes containing the ISAba1 directly upstream of bla OXA-51 show resistance to carbapenems. 497
It is likely that ISAba1 is acting as the promoter for bla OXA-51 in TG29392, conferring resistance to 498 carbapenems (22). The intermediate resistance strain, TG31307, has both ISAba1 and bla OXA-51 ; 499 however, ISAba1 is downstream of bla OXA-51 and therefore not functioning as a strong promoter 500 for the beta-lactamase gene (Figure 4b ). An analysis of the coding region of the bla OXA-51 gene in 501 both isolates revealed no differences, suggesting that differences in expression are due to 502 expression. 503
Interestingly, several of the CDSs that were differentially expressed in the resistant strain in 504
Pair 2 were up-regulated in the intermediate Pair 3 strain (TG31307). For example, recA was 505 the most differentially expressed gene in Pair 3 genomes, but was up-regulated in TG31307 506 (Table S8 ). This suggests that the mechanisms of resistance have complex interactions that 507 need to be investigated through targeted gene deletions. 508 509 Pair 4. Of the numerous differences in gene expression between the resistant (TG22653) and 510 intermediate strain (TG60155), perhaps the most striking is in the expression of carO 511 (EA719_004515), an outer membrane porin (Table S9 ). Previous analyses have demonstrated 512 that insertion sequences that disrupt carO are associated with decreased activity against beta-513 lactams (99). The genome assembly of the intermediate strain, TG60155, shows that carO is 514 interrupted by the insertion sequence, ISAba1 (EA720_015165) (Figure 4c ). An analysis of the 515 transcriptome of TG60155 also failed to identify an intact carO transcript, which was present in 516 TG22653. 517 518 Antimicrobial resistance induction analysis. In an effort to observe induced antimicrobial 519 resistance in the four paired isolates, resistant strains were grown in sub-inhibitory 520 concentrations of select antimicrobials. Differential expression of each sub-inhibitory isolate was 521 compared to the isolate grown under inhibitory concentrations using the Wald statistic produced 522 from DESeq2. Additionally, the resistant isolate TG22653 was grown under two different sub-523 inhibitory concentrations of antimicrobials (16 and 258); differential expression from these two 524 concentrations was also compared. No significant differential expression was observed in the 525 four analyses based on an FDR-adjusted p-value of 0.05. Likewise, using the Wald statistic from 526 these analyses also demonstrated no significant differential expression between the differing 527 antimicrobial concentrations using the chosen threshold. This suggests that differential 528 expression is due to constitutively expressed mechanisms that are not inducible. 529 530 AmpSeq validation. Amplicon sequencing was performed on cDNA to not only confirm the 531 RNA-Seq results, but also to provide a proof of concept as an advanced AMR diagnostic. 532
Comparative expression was identified through comparison of ratios of the number of read 533 counts of each targeted gene compared to a housekeeping gene (IX87_18340); the 534 housekeeping gene was identified as a gene with consistent, and relatively high, expression in 535 the RNA-Seq data. For pair 1, the bla PER-1 and aphA1 genes were significantly upregulated in 536 the resistant strain compared to the intermediate strain (Table 6) . For pair 2, the expression of 537 the ampC gene was not significantly different, suggesting that differential expression of this 538 region doesn't explain the resistance phenotype and is consistent with the RNA-Seq data. For 539 pair 3, the bla OXA-51 gene was confirmed to be significantly up-regulated in the resistant strain 540 compared to the intermediate strain. For pair 4, the carO gene was significantly up-regulated in 541 the resistant strain, which is consistent with the RNA-Seq results and is likely the primary 542 mechanism of resistance. A gene associated with the production of a spore-coat forming protein 543 (CsuA/B) was highly up-regulated in the resistant strain. While not directly associated with AMR, 544 this validation provides confidence in the RNA-Seq data. 545 546 General transcriptome screen. A LS-BSR analysis of previously described resistance 547 mechanisms (Table S3 ) between the genome and transcriptome demonstrated that some 548 genomic regions, such as the adeF gene, were highly conserved in the genome, but were 549 largely absent from the transcriptome (Table S10 ). This finding demonstrates the importance of 550 incorporating gene expression when trying to understand phenotypic differences. 551 552 Discussion: 553 554 Antimicrobial resistance (AMR) is a significant, emerging threat, with A. baumannii being 555 recently classified as a priority 1 pathogen (2). Some mechanisms associated with AMR in A. 556 baumannii are clearly understood, especially with regards to documented beta lactamases (100-557 103) and efflux pumps (15, 104, 105) . However, the highly plastic pan-genome of A. baumannii 558 (45) suggests that the identification of universal AMR mechanisms may be unlikely, even with 559 regard to the presence and activity of specific beta-lactamases. This same trend has been 560 observed in other highly plastic genomes, such as Pseudomonas aeruginosa (106), and 561 complicates surveillance and targeted therapy efforts. As such, A. baumannii is not only an 562 emerging threat, but represents a critical challenge to the development of both novel drugs and 563 molecular diagnostics. 564
In this study, we sequenced 107 genomes reported to be A. baumannii based on testing in 565 the clinical laboratory. Typing based on WGS analyses identified 23 of the genomes were 566 misclassified and belonged to other Acinetobacter species (Table S1 ). These incorrect clinical 567 laboratory typing results highlight the need for improved clinical diagnostics of A. baumannii. An 568 additional 35 genomes in the GenBank assembly database were incorrectly annotated as A. 569
baumannii and belonged to other species (not shown), which further demonstrates the difficulty 570 in typing as well as and the impact of mis-annotated genomes on population structure analysis 571 in Acinetobacter. Typing strains using WGS should be a first step in any large comparative 572 genomics study to limit the analysis to a targeted group, clade, or species. 573
We generated antibiograms for 12 drugs, representing multiple drug families, across the 84 574 isolates confirmed to belong to A. baumannii by WGS analysis. Some of the drugs screened in 575 this study aren't typically used in current treatment regimens for A. baumannii infections. 576 However, with growing resistance emerging to next generation drugs, clinicians are exploring 577 older drugs (e.g. chloramphenicol) to treat emerging threats (42, 107) . In this study, we sought 578 to identify genomic differences that could explain the variable resistance phenotypes using 579 established antimicrobial resistance gene databases as a method to predict AMR from 580 genomics data (31, 32, 35, 60) . A screen of regions from the Comprehensive Antimicrobial 581
Resistance Database (CARD) against genomes sequenced in this study failed to identify 582 characterized resistance mechanisms that largely explain the resistance phenotype. These 583 results demonstrate the limitations to this approach in highly plastic species, such as A. 584 baumannii, and suggest that alternative approaches including RNA-seq data may be required 585 for a comprehensive understanding of AMR mechanisms in A. baumannii. 586 We then employed reference independent, genome wide association study (GWAS) 587 methods to identify genomic differences between susceptible/intermediate/resistant phenotypes. 588
These types of associations have been used in other pathogens to identify genotype/phenotype 589 associations (108). In general, we failed to identify a clear association between the genotype 590 (21bp Kmers, coding regions, SNPs) and the resistance phenotype when comparing either all 591
Acinetobacter genomes or just A. baumannii genomes (Table 4 ). This result suggests that 592 diverse and independent mechanisms may be responsible for the AMR phenotype for some 593 drugs instead of single, highly conserved mechanisms. 594
Recent research has demonstrated difficulty identifying complex mechanisms, or under-or-595 over-represented phenotypes, using a GWAS approach (109) . As a way to focus on sparsely 596 distributed AMR mechanisms, a paired isolate approach was utilized in order to reduce noise in 597 the genomic background. In this analysis, four isolate pairs were individually compared across 598 four antimicrobials (Table 2) . RNA-Sequencing (RNA-Seq) of these four paired 599 resistant/intermediate isolates that shared a common genetic background was employed. Using 600 this approach, several potential mechanisms were identified, some of which have been 601 identified previously in A. baumannii, but are difficult to identify with standard comparative 602 genomics approaches, requiring RNASeq for comprehensive surveillance. While we identified 603 known resistance mechanisms in the resistant strains, some of those regions were also 604 identified in intermediate strains; previous studies of A. baumannii transcriptomes have also 605 observed up-regulation of resistance and efflux genes in susceptible strains (5). RNASeq data 606 allowed for the identification of antimicrobial resistance mechanisms that while present in both 607 the resistant and susceptible genomes, were differentially expressed due to an upstream 608 insertion element. These results also highlight the possibility that expression of a single AMR 609 gene does not always confer resistance and it is likely that combinations of genes are 610 responsible for observed resistance. Differential expression differences were confirmed using a 611 cDNA-AmpSeq approach and largely confirmed the differential expression of targeted regions. 612
Previous research has demonstrated a bias of differentially expressed regions when applying a 613 multiplexed PCR approach (110). We addressed this issue by optimizing primer concentrations 614 using genomic DNA and including a single copy number gene for normalization. 615
The results of this study demonstrate that, due to the plastic nature of A. baumannii's pan-616 genome, comprehensive AMR surveillance cannot solely be achieved through genomics 617 methods alone, especially with current AMR databases and commonly used analytical methods. 618
This study demonstrates that AMR genes are not conserved across A. baumannii lineages with 619 similar AMR profiles and that solely relying on genomics methods for AMR surveillance and 620 discovery, such as gene presence/absence, will fail to detect novel or recently acquired AMR 621 mechanisms. For instance, identifying only the position of insertion sequence (IS) elements 622 throughout a genome using genomic tools provides little resolution to inform of possible AMR 623 genes upregulated by the presence of upstream IS elements. Furthermore, identification of 624 these elements would provide little resolution of antimicrobial resistance profiles in a clinical 625 setting. However, by utilizing transcriptome data, we were able to identify AMR genes 626 upregulated by these elements as well as novel AMR mechanisms, and design rapid cDNA 627 amplicon sequencing targets for these mechanisms to improve surveillance and diagnostic 628 efforts. 629 630 Funding. Funding for this project was provided by an R21 grant awarded to JWS 631 (1R21AI121738-01). DME is supported in part by CDC contract 200-2016-92313. 632 633 (Table S3) 
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